« Previous
Next »
Journal of Vascular Surgery
Volume 48, Issue 3
, Pages
546-554.e2
, September 2008
Pivotal results of the Medtronic Vascular Talent Thoracic Stent Graft System: The VALOR Trial
-
A, The Talent Thoracic Stent Graft Device consists of a polyester graft fabric sewn to a self-expanding nickel-titanium (chemically polished nitinol) wire frame. B, The modular design concept of the T
A, The Talent Thoracic Stent Graft Device consists of a polyester graft fabric sewn to a self-expanding nickel-titanium (chemically polished nitinol) wire frame. B, The modular design concept of the Talent Thoracic Stent Graft Device is illustrated.
-
Flow chart shows follow-up for participants in the participants Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial.Flow chart shows follow-up for participants in the participants Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial.
-
Kaplan-Meier plot of freedom from all-cause mortality for Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial participaKaplan-Meier plot of freedom from all-cause mortality for Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial participants (solid line) and the open surgery cohort (dashed line).
-
Kaplan-Meier plot of freedom from aneurysm-related mortality for Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial paKaplan-Meier plot of freedom from aneurysm-related mortality for Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial participants (solid line) and the open surgery cohort (dashed line).
-
Kaplan-Meier plot of freedom from major adverse events at 30 days for Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) triKaplan-Meier plot of freedom from major adverse events at 30 days for Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR) trial participants (solid line) and the open surgery cohort (dashed line).
Supported by Medtronic Vascular.
Competition of interest: none.
Additional material for this article may be found online at www.jvascsurg.org.
PII: S0741-5214(08)00511-9
doi: 10.1016/j.jvs.2008.03.061
© 2008 The Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 48, Issue 3
, Pages
546-554.e2
, September 2008
